PARP‐1‐mediated poly(ADP‐ribosyl)ation of FOXP3 impairs Treg function and suggests that PARP‐1 inhibitor could be potential drug for autoimmune diseases (Luo et al, 2015). The gene discussed is PARP1; the disease is autoimmune disease.